Sun Pharma recalls antidepressant drug from US market

Tags: Companies
Caraco Pharmaceutical Laboratories, a subsidiary of Sun Pharma, has initiated recall of some lots of Venlafaxine Hydrochloride extended-release tablets from the US market.

According to a notification by the FDA, the recall of 26,530 units of 30-count bottles and 14,597 units of 90-count bottles is voluntarily initiated by the company through a letter to the regulator last month under 'Class-II' classification.

Venlafaxine Hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder.

"Stability results found the product did not meet the drug release dissolution specifications," the regulator's website said.

Tablet dissolution is a standardised method for measuring the rate of drug release from a dosage form.

The recalled drug bottles were distributed by Caraco Pharmaceutical Laboratories Ltd in USA, while manufactured at Halol plant in Gujarat by Sun Pharmaceutical Industries Ltd.

According to the US health regulator, Class II recall is a situation in which the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.


  • The govt's objective to make air travel more accessible, is welcome

    The feel good factor is bound to percolate down the line to the ‘aam admi’ looking for ‘achche din’, in case the regional air connectivity sch


Stay informed on our latest news!


Sachin Shridhar

Building the nation, babu-style

Home Minister Rajnath Singh has promised that the India-Pakistan ...

Zehra Naqvi

Of absolute truth & relative perception

Is there such a thing as absolute truth? Look around ...

Shona Adhikari

Owais Husain searches for a lost homeland

The seventh edition of the Mumbai Public Art Festival (PAF) ...